海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- IMPACT D’UNE INTENSIFICATION THERAPEUTIQUE PAR INHIBITEUR D’INTEGRASE +/- INHIBITEUR DE CCR5 SUR LE RESERVOIR LYMPHOÏDE DU VIH-1 CHEZ DES PATIENTS AU STADE CHRONIQUE DE L’INFECTION - IntensVIH
- Infection à VIH-1
- France
- 2009-10-01
Not recruiting
- Adherence to PTH(1-84) Treatment (FP-002-IM)
- Clinical Use of PTH(1-84);Clinical Use of PTH(1-84);Clinical Use of PTH(1-84);Clinical Use of PTH(1-84)
- Denmark, Germany
- 2007-05-23
Not Recruiting
- Effect of GLP-1 on microvascular function in patients with type 2 diabetes
- Microvessel angina is a result of myocardial ischemia from insufficient myocardial perfusion secondary to microvessel dysfunction. Diseased arteries may appear angiographically normal but are dysfunctioning and blood flow is not sufficient increased. In the absence of stenosis of major coronary arteries, coronary flow reserve (CFR) reflects coronary microcirculation. CFR is reduced in patients diabetes and is a strong predictor of poor prognosis. MedDRA version: 14.1 Level: LLT Classification code 10065566 Term: Microvascular angina System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Denmark
- 2013-02-04
Authorised
- Adjusting antidepressant dosage according to the patient's ABCB1 genotype
- - Major Depression, single or recurrent, without psychotic features - Bipolar Disorders, currently depressed, without psychotic features MedDRA version: 14.1 Level: PT Classification code 10057840 Term: Major depression System Organ Class: 10037175 - Psychiatric disorders MedDRA version: 14.1 Level: PT Classification code 10004939 Term: Bipolar I disorder System Organ Class: 10037175 - Psychiatric disorders MedDRA version: 14.1 Level: PT Classification code 10004940 Term: Bipolar II disorder System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Germany
- 2011-08-16
Not recruiting
- GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
- Obesity;Obesity;Obesity
- Denmark
- 2014-03-06
Not recruiting
- Role of Endothelin-1 in Flow-mediated Dilatation
- Healthy Conditions
- France
- 2014-02-18
Not recruiting
- Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1
- Drug Metabolism;Membrane Transport
- Germany
- 2014-01-30
Authorised
- GLP-1 and hyperoxia for organ protection in heart surgery
- We investigate the efficacy of commercially available GLP-1 analog for reducing organ damage in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or aortic valve replacement). In addition we investigate the efficacy of restrictive versus liberal oxygenation (i.e. FiO2 50% versus FiO2 100%) for reducing organ damage during weaning after heart surgery. The study is a two-by-two factorial designed randomized clinical trial. MedDRA version: 20.0 Level: LLT Classification code 10008937 Term: Chronic ischemic heart disease, unspecified System Organ Class: 100000011627 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Denmark
- 2015-07-20
Recruiting
- The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- Diabetes Mellitus Type 2
- Spain
- 2015-07-16
Recruiting
- EFFECTS OF LINAGLIPTIN ON ACTIVE GLP-1 CONCENTRATIONS IN SUBJECTS WITH RENAL IMPAIRMENT
- Diabetes Mellitus;E11 - Non-insulin-dependent diabetes mellitus
- Germany
- 2015-04-14